BioVaxys Technology Corp. (CSE:BIOV, OTCQB:BVAXF, FR:5LB), formerly BioVaxys LLC, is a British Columbia-registered clinical-stage biotechnology company dedicated to improving patient lives with novel immunotherapies based on our DPX™ immune-educating delivery technology platform and our HapTenix© neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields.
The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase IIb clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using our proprietary HapTenix© neoantigen tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer.
BioVaxys is capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 146 Thirtieth Street Canada,
- Phone
- 610 977 2440
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- biovaxys.com
- Keywords
- Oncology, Biotechnology, Melanoma, Ovarian Cancer, Cancer Vaccines, Immunotherapeutics, Cancer, Vaccine, virology, Personalized Immunotherapy, lipid delivery, drug delivery.
- HQ
- Etobicoke, Ontario
Biovaxys Technology Corp. Questions
Biovaxys Technology Corp.'s helpline number is 610 977 2440
Biovaxys Technology Corp.'s website is biovaxys.com
Biovaxys Technology Corp.'s LinkedIn profile is https://www.linkedin.com/company/biovaxys-llc
Biovaxys Technology Corp. has
5 employees.
View email and phone details for 5
employees at Biovaxys Technology Corp..
Biovaxys Technology Corp.'s industry is
Biotechnology Research
Biovaxys Technology Corp.'s top competitors are
Accession Therapeutics Limited,
Pinetree Therapeutics Inc,
Aoa Dx,
Duo Oncology,
Incyclix Bio,
Lassogen, Inc.,
Rocky Health,
Singula Bio Ltd.,
Omideon Limited,
Upyther.
Biovaxys Technology Corp.'s categories are Biotechnology Research
Biovaxys Technology Corp.'s founding year is 2020
